Anosmin-1 involved in neuronal cell migration is hypoxia inducible and cancer regulated

Cell Cycle

Volumn 8, Issue 22, 2009, Pages 3770-3776

  Jian, Bixi ^a   Nagineni, Chandrasekharam N ^b   Meleth, Sreelatha ^c   Grizzle, William ^d   Bland, Kirby ^a   Chaudry, Irshad ^a,e   Raju, Raghavan ^a,e  

^a Kentucky   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

Anosmia; Anosmin; Apoptosis; Colon cancer; HIF 1 ; Hypogonadism; Metastasis; Tumor

Indexed keywords

ANOSMIN 1; COMPLEMENTARY DNA; GONADORELIN; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEVELOPMENT; CANCER CELL CULTURE; CANCER GROWTH; CANCER SCREENING; CANCER STAGING; CELL MIGRATION; CELL MOTILITY; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHALAMUS; LUNG CANCER; NERVE CELL; OLFACTORY CORTEX; OVARY CANCER; PATHOPHYSIOLOGY;

EID: 70449769718     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.22.10066     Document Type: Article

References (30)

1. MacColl G, Bouloux P, Quinton R. Kallmann syndrome: adhesion, afferents and anosmia. Neuron 2002; 34:675-678 (Pubitemid 34628731)
2. Soussi-Yanicostas N, de Castro F, Julliard AK, Perfettini I, Chedotal A, Petit C. Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons. Cell 2002; 109:217-228 (Pubitemid 34518260)
3. Soussi-Yanicostas N, Hardelin JP, Arroyo-Jimenez MM, Ardouin O, Legouis R, Levilliers J, et al. Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci 1996; 109:1749-1757 (Pubitemid 26248620)
4. Robertson A, MacColl GS, Nash JA, Boehm MK, Perkins SJ, Bouloux PM. Molecular modelling and experimental studies of mutation and cell-adhesion sites in the fibronectin type III and whey acidic protein domains of human anosmin-1. Biochem J 2001; 357:647-659 (Pubitemid 32735146)
5. Kim SH, Hu Y, Cadman S, Bouloux P. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome. J Neuroendocrinol 2008; 20:141-163 (Pubitemid 351147002)
6. Hardelin JP, Julliard AK, Moniot B, Soussi-Yanicostas N, Verney C, Schwanzel-Fukuda M, et al. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn 1999; 215:26-44.
7. Raju R, Dalakas MC. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 2005; 128:1887-1896
8. Xu Y, Pasche B. TGFbeta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007; 16:14-20.
9. Prud'homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007; 87:1077-1091
10. Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 2006; 70:1234-1243
11. Gadir N, Lee E, Garcia A, Toschi A, Foster DA. Suppression of TGFbeta signaling by phospholipase D. Cell Cycle 2007; 6:2840-2845
12. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134:1570-1595
13. Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, et al. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta1. Exp Cell Res 1989; 181:442-453 (Pubitemid 19096410)
14. Nagineni CN, Cherukuri KS, Kutty V, Detrick B, Hooks JJ. Interferon-gamma differentially regulates TGFbeta1 and TGFbeta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway. J Cell Physiol 2007; 210:192-200. (Pubitemid 44904715)
15. Jian B, Hsieh C-H, Chen J, Choudhry M, Bland B, Chaudry I, et al. Activation of Endoplasmic reticulum stress response following trauma-hemorrhage. Biochim Biophys Acta 2008; 1782:621-626
16. Gonzalez-Martinez D, Kim SH, Hu Y, Guimond S, Schofield J, Winyard P, et al. Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. J Neurosci 2004; 24:10384-10392
17. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005:12.
18. Gonzalez-Martinez D, Hu Y, Bouloux PM. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Front Neuroendocrinol 2004; 25:108-130 (Pubitemid 39572201)
19. Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 2008; 60:591-597
20. Lofstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, et al. Hypoxia inducible factor-2alpha in cancer. Cell Cycle 2007; 6:919-926
21. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-939 (Pubitemid 38798858)
22. Yang MH, Wu KJ. TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 2008; 7:2090-2096
23. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33:463-465 (Pubitemid 36390006)
24. McMahon S, Charbonneau M, Grandmont S, Richard DE, Dubois CM. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 2006; 281:24171-24181
25. 2-regulated prolyl hydroxylation. Science 2001; 292:468-472
26. Yu F, White SB, Zhao Q, Lee FS. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 2001; 98:9630-9635 (Pubitemid 32769354)
27. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56:4509-4515
28. Teicher BA, Dupuis NP, Robinson MF, Kusumoto T, Liu M, Menon K. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing. In Vivo 1994; 8:125-131 (Pubitemid 24156543)
29. Tirasophon W, Welihinda AA, Kaufman RJ. A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev 1998; 12:1812-1824.
30. van den BT, Koritzinsky M, Wouters BG. Translational control of gene expression during hypoxia. Cancer Biol Ther 2006; 5:749-755